| Issue Date | Title | Author(s) |
| 12-Aug-2022 | Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting | Scarffe, AD; Licskai, CJ; Ferrone, M; Brand, K; Thavorn, K; Coyle, D |
| 2006 | Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data | Briggs, AH; Lozano-Ortega, G; Spencer, S; Bale, G; Spencer, MD; Burge, PS |
| 20-Jan-2023 | Frailty and Mortality Risk in COPD: A Cohort Study Comparing the Fried Frailty Phenotype and Short Physical Performance Battery | Brighton, LJ; Nolan, CM; Barker, RE; Patel, S; Walsh, JA; Polgar, O; Kon, SSC; Gao, W; Evans, CJ; Maddocks, M; Man, WDC |
| 2020 | Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multi-centre, double-blind, placebo-controlled, randomised parallel group study | Pavitt, M; Tanner, R; Lewis, A; Buttery, S; Mehta, B; Jefford, H; Curtis, K; Banya, W; Hussain, S; Karnan, S; Shrikrishna, D; Man, W; Polkey, M; Hopkinson, N |
| 8-Dec-2023 | Smoking and pre-existing co-morbidities as risk factors for developing severity of COVID-19 infection: Evidence from a field hospital in a rural area of Bangladesh | Ahmed, S; Chakma, SK; Mahmud, T; Mamun, AA; Islam, Z; Islam, MM |
